Cargando…

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model

BACKGROUND: Alzheimer's Disease (AD) affects a growing proportion of the population each year. Novel therapies on the horizon may slow the progress of AD symptoms and avoid cases altogether. Initiating treatment for the underlying pathology of AD would ideally be based on biomarker screening to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furiak, Nicolas M, Klein, Robert W, Kahle-Wrobleski, Kristin, Siemers, Eric R, Sarpong, Eric, Klein, Timothy M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152764/ https://www.ncbi.nlm.nih.gov/pubmed/20433705 http://dx.doi.org/10.1186/1472-6947-10-24

Ejemplares similares

Assessing quality of life in Alzheimer's disease: Implications for clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2016)

Modeling the course of Alzheimer's disease to improve clinical trials: symposium report
por: Spiegel, René, et al.
Publicado: (2013)

Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model
por: Furiak, Nicolas M, et al.
Publicado: (2012)

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery, William, et al.
Publicado: (2018)

Alzheimer’s disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey
por: Montgomery, William, et al.
Publicado: (2018)

Impact of caring for persons with Alzheimer’s disease or dementia on caregivers’ health outcomes: findings from a community based survey in Japan
por: Goren, Amir, et al.
Publicado: (2016)

Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer’s disease patients
por: Gilden, Daniel M, et al.
Publicado: (2014)

Understanding the Complexities of Functional Ability in Alzheimer’s Disease: More Than Just Basic and Instrumental Factors
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer’s disease: A matched case–control study
por: Porter, Candace N, et al.
Publicado: (2016)

A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease
por: Liu-Seifert, Hong, et al.
Publicado: (2015)

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States
por: Furiak, Nicolas M, et al.
Publicado: (2009)

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
por: Reed, Catherine, et al.
Publicado: (2018)

Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease
por: Kirson, Noam Y., et al.
Publicado: (2017)

Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists
por: Kirson, Noam Y., et al.
Publicado: (2016)

Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models
por: Sanghera, Sabina, et al.
Publicado: (2018)

2825. Clinician Treatment Considerations and Decisions in Hypothetical Uncomplicated Urinary Tract Infection Patient Vignettes
por: Ellis, Jeffrey J, et al.
Publicado: (2023)

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease
por: Lebrec, Jeremie, et al.
Publicado: (2016)

Using Decision-Analytic Models Wisely
por: Hakim, Zafar
Publicado: (2003)

The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study
por: Goodall, Gordon, et al.
Publicado: (2009)

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
por: Nakanishi, Miharu, et al.
Publicado: (2020)

Maternal Serologic Screening to Prevent Congenital Toxoplasmosis: A Decision-Analytic Economic Model
por: Stillwaggon, Eileen, et al.
Publicado: (2011)

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
por: Jones, Roy W., et al.
Publicado: (2017)

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
por: Belger, Mark, et al.
Publicado: (2016)

Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years
por: Liu-Seifert, Hong, et al.
Publicado: (2015)

Prevention of congenital toxoplasmosis in France using prenatal screening: A decision-analytic economic model
por: Sawers, Larry, et al.
Publicado: (2022)

Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
por: Yokoyama, Jennifer S, et al.
Publicado: (2015)

Function and clinical meaningfulness of treatments for mild Alzheimer's disease
por: Siemers, Eric, et al.
Publicado: (2016)

Modeling the Impact of Delaying Bariatric Surgery due to COVID-19: a Decision Analysis
por: Shipe, Maren E., et al.
Publicado: (2020)

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
por: Krafft, Grant A., et al.
Publicado: (2022)

Comparative Clinical Effectiveness of Population‐Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision‐Analytic Model
por: Khurshid, Shaan, et al.
Publicado: (2021)

Mind+machine: a decision model for optimizing and implementing analytics
por: Vollenweider, Marc
Publicado: (2016)

The Role of decision-analytic modelling in German health technology assessments
por: Kuhlmann, Alexander, et al.
Publicado: (2015)

Application of the decision tree model in ADHD screening
por: Carreiro, L.R., et al.
Publicado: (2021)

Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model
por: Baldwin, Paige, et al.
Publicado: (2019)

Personalized Prehospital Triage in Acute Ischemic Stroke: A Decision-Analytic Model
por: Venema, Esmee, et al.
Publicado: (2019)

Additional offer of sigmoidoscopy in colorectal cancer screening in Germany: rationale and protocol of the decision-analytic modelling approach in the SIGMO study
por: Diedrich, Leonie, et al.
Publicado: (2022)

Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling
por: Steyerberg, Ewout W., et al.
Publicado: (2021)

Analytic geometry
por: Rees, Paul Klein
Publicado: (1970)

Cost-effectiveness of incorporating Ebola prediction score tools and rapid diagnostic tests into a screening algorithm: A decision analytic model
por: Tshomba, Antoine Oloma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1or0sd1hoge9185kdi7sfmg4lu